GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Redcare Pharmacy NV (WBO:SHOP) » Definitions » Equity-to-Asset

Redcare Pharmacy NV (WBO:SHOP) Equity-to-Asset : 0.51 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Redcare Pharmacy NV Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Redcare Pharmacy NV's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €522 Mil. Redcare Pharmacy NV's Total Assets for the quarter that ended in Dec. 2023 was €1,022 Mil. Therefore, Redcare Pharmacy NV's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.51.

The historical rank and industry rank for Redcare Pharmacy NV's Equity-to-Asset or its related term are showing as below:

WBO:SHOP' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06   Med: 0.58   Max: 0.8
Current: 0.51

During the past 11 years, the highest Equity to Asset Ratio of Redcare Pharmacy NV was 0.80. The lowest was 0.06. And the median was 0.58.

WBO:SHOP's Equity-to-Asset is ranked better than
54.69% of 671 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs WBO:SHOP: 0.51

Redcare Pharmacy NV Equity-to-Asset Historical Data

The historical data trend for Redcare Pharmacy NV's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redcare Pharmacy NV Equity-to-Asset Chart

Redcare Pharmacy NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.79 0.53 0.49 0.51

Redcare Pharmacy NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.46 0.47 0.48 0.51

Competitive Comparison of Redcare Pharmacy NV's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redcare Pharmacy NV's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's Equity-to-Asset falls into.



Redcare Pharmacy NV Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Redcare Pharmacy NV's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=522.194/1021.596
=0.51

Redcare Pharmacy NV's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=522.194/1021.596
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Redcare Pharmacy NV  (WBO:SHOP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Redcare Pharmacy NV Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Redcare Pharmacy NV's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Redcare Pharmacy NV (WBO:SHOP) Business Description

Traded in Other Exchanges
Address
Erik de Rodeweg 11/13, Sevenum, NLD, 5975 WD
Redcare Pharmacy NV Formerly Shop Apotheke Europe NV operates an online pharmacy store. Its product portfolio is focused on non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue domestically from the DACH segment. Geographically, it has a presence in Germany, Belgium, Spain, France, and Italy.

Redcare Pharmacy NV (WBO:SHOP) Headlines

From GuruFocus

Shopify Is Up Against It

By Steve Gray Booyens 07-28-2022

UBS ASSET MANAGEMENT AMERICAS INC Buys 2, Sells 3 in 1st Quarter

By GuruFocus Research GuruFocus Editor 05-19-2022

Shopify's New Model Is Paying Dividends

By Muslim Farooque 11-01-2022

Ron Baron Comments on Shopify

By Sydnee Gatewood 11-08-2022

Egerton Capital (UK) LLP Buys 1, Sells 4 in 1st Quarter

By GuruFocus Research GuruFocus Editor 08-04-2022

Shopify: Great Business, Horrible Price

By Jonathan Poland 02-17-2023